StudyManager Reveal Now Features Patient Registration Interface
StudyManager announced that it has added a patient registration interface to its Reveal CTMS software, enabling research sites, academic medical centers and health systems to integrate Reveal with a variety of electronic health record systems.
Built using HL7 protocols, the new interface increases the efficiency of healthcare providers by seamlessly and automatically synchronizing demographic data for research patients with centralized hospital or clinic records. As a result, clinical staff working on research projects no longer need to double-enter demographic data or worry that critical contact information is not synchronized with hospital records.
The interface also helps improve patient safety by enabling research staff to more quickly determine whether a patient being recruited for (or treated within) a clinical trial has information stored within the hospital’s electronic health record (EHR) system. Research staff can then use the EHR to determine whether treatment received within a clinical trial medically conflicts with other treatment received within the health system, or vice-versa.
“Integrating the healthcare delivery enterprise with the clinical research enterprise is an important step in the process of lowering the cost of research for healthcare providers,” said Bruce Schatzman, CEO at StudyManager. “At many institutions, research is not well connected with core healthcare delivery, and this new interface helps eliminate the operational and safety problems this disconnection creates.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
